| Potentiating cancer immunotherapy using an oncolytic virus BW Bridle, KB Stephenson, JE Boudreau, S Koshy, N Kazdhan, ... Molecular Therapy 18 (8), 1430-1439, 2010 | 214 | 2010 |
| Maraba virus as a potent oncolytic vaccine vector JG Pol, L Zhang, BW Bridle, KB Stephenson, J Rességuier, S Hanson, ... Molecular therapy 22 (2), 420-429, 2014 | 194 | 2014 |
| Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus BW Bridle, JE Boudreau, BD Lichty, J Brunellière, K Stephenson, S Koshy, ... Molecular therapy 17 (10), 1814-1821, 2009 | 127 | 2009 |
| Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti … KB Stephenson, NG Barra, E Davies, AA Ashkar, BD Lichty Cancer gene therapy 19 (4), 238-246, 2012 | 126 | 2012 |
| Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy PT Sobol, JE Boudreau, K Stephenson, Y Wan, BD Lichty, KL Mossman Molecular Therapy 19 (2), 335-344, 2011 | 113 | 2011 |
| Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity JE Boudreau, BW Bridle, KB Stephenson, KM Jenkins, J Brunellière, ... Molecular Therapy 17 (8), 1465-1472, 2009 | 95 | 2009 |
| Endogenous T cells prevent tumor immune escape following adoptive T cell therapy SR Walsh, B Simovic, L Chen, D Bastin, A Nguyen, K Stephenson, ... The Journal of clinical investigation 129 (12), 5400-5410, 2019 | 89 | 2019 |
| S6K-STING interaction regulates cytosolic DNA–mediated activation of the transcription factor IRF3 F Wang, T Alain, KJ Szretter, K Stephenson, JG Pol, MJ Atherton, ... Nature immunology 17 (5), 514-522, 2016 | 86 | 2016 |
| Surgical stress abrogates pre-existing protective T cell mediated anti-tumor immunity leading to postoperative cancer recurrence AA Ananth, LH Tai, C Lansdell, AA Alkayyal, KE Baxter, L Angka, J Zhang, ... PloS one 11 (5), e0155947, 2016 | 85 | 2016 |
| Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease J Zhang, LH Tai, CS Ilkow, AA Alkayyal, AA Ananth, CT De Souza, ... Molecular therapy 22 (7), 1320-1332, 2014 | 79 | 2014 |
| Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials JG Pol, SA Acuna, B Yadollahi, N Tang, KB Stephenson, MJ Atherton, ... Oncoimmunology 8 (1), e1512329, 2019 | 70 | 2019 |
| The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis CW Brown, KB Stephenson, S Hanson, M Kucharczyk, R Duncan, JC Bell, ... Journal of virology 83 (2), 552-561, 2009 | 70 | 2009 |
| Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation FW Lai, KB Stephenson, J Mahony, BD Lichty Journal of virology 88 (1), 54-65, 2014 | 68 | 2014 |
| IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells JE Boudreau, KB Stephenson, F Wang, AA Ashkar, KL Mossman, LL Lenz, ... Cancer research 71 (7), 2497-2506, 2011 | 63 | 2011 |
| Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer AJR McGray, RY Huang, S Battaglia, C Eppolito, A Miliotto, ... Journal for immunotherapy of cancer 7, 1-16, 2019 | 50 | 2019 |
| Development and applications of oncolytic Maraba virus vaccines JG Pol, MJ Atherton, BW Bridle, KB Stephenson, F Le Boeuf, JL Hummel, ... Oncolytic virotherapy, 117-128, 2018 | 49 | 2018 |
| Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells BI Bassey-Archibong, JM Kwiecien, SB Milosavljevic, RM Hallett, ... Oncogenesis 5 (3), e208-e208, 2016 | 45 | 2016 |
| Customized viral immunotherapy for HPV-associated cancer MJ Atherton, KB Stephenson, J Pol, F Wang, C Lefebvre, DF Stojdl, ... Cancer immunology research 5 (10), 847-859, 2017 | 40 | 2017 |
| Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination DG Roy, K Geoffroy, M Marguerie, ST Khan, NT Martin, J Kmiecik, ... Nature Communications 12 (1), 2626, 2021 | 39 | 2021 |
| Separate roles of IL‐6 and oncostatin M in mouse macrophage polarization in vitro and in vivo A Dubey, L Izakelian, EA Ayaub, L Ho, K Stephenson, S Wong, K Kwofie, ... Immunology and Cell Biology 96 (3), 257-272, 2018 | 29 | 2018 |
